Literature DB >> 7518454

Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis.

V Mizrahi1, R L Brooksbank, N C Nkabinde.   

Abstract

The effects of point mutations of the conserved Asp443, Glu478, Asn494, and Asp498 residues in the RNase H domain of human immunodeficiency virus type I (HIV-1) reverse transcriptase (RT) have been analyzed. The mutants fell into two classes: (i) functional RT, but not detectable ribonuclease H activity, and (ii) uncharacterizable phenotype due to protein instability in the context of the RT/protease Escherichia coli co-expression system (Mizrahi, V., Lazarus, G. M., Miles, L. M., Meyers, C. A., and Debouck, C. (1989) Arch. Biochem. Biophys. 273, 347-358). The only mutation in the former class was D443A, whereas those in the latter included D443E, E478D, E478Q, D498E, D443A/D498N, D443E/D498N, D443Q/D498N, N494A, N494D, and N494Q. The results were interpreted in terms of the x-ray crystal structure of the HIV-1 RNase H domain (Davies, J. F., II, Hostomaska, Z., Hostomsky, Z., Jordan, S. R., and Matthews, D. A. (1991) Science 252, 88-95) and a general acid-general base hydrolysis mechanism (Katayanagi, K., Okumura, M., and Morikawa, K. (1993) Proteins Struct. Funct. Genet. 17, 337-346). The data suggested that structural perturbations within the RNase H domain interfered with maturation of the pol precursor by HIV-1 protease. Analysis of selected D443/D498 double mutants suggested that the destabilization caused by the D498N mutation could be suppressed by the formation of a new hydrogen bond between Asn498 and Asn443.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518454

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  The reverse transcriptase of the Tf1 retrotransposon has a specific novel activity for generating the RNA self-primer that is functional in cDNA synthesis.

Authors:  Amnon Hizi
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity.

Authors:  S W Blain; W A Hendrickson; S P Goff
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  An unusual mechanism of self-primed reverse transcription requires the RNase H domain of reverse transcriptase to cleave an RNA duplex.

Authors:  H L Levin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

5.  Deoxy- and dideoxynucleotide discrimination and identification of critical 5' nuclease domain residues of the DNA polymerase I from Mycobacterium tuberculosis.

Authors:  V Mizrahi; P Huberts
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

6.  Evaluation of anti-HIV-1 mutagenic nucleoside analogues.

Authors:  Valérie Vivet-Boudou; Catherine Isel; Yazan El Safadi; Redmond P Smyth; Géraldine Laumond; Christiane Moog; Jean-Christophe Paillart; Roland Marquet
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

Review 7.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

8.  Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.

Authors:  Hua-Poo Su; Youwei Yan; G Sridhar Prasad; Robert F Smith; Christopher L Daniels; Pravien D Abeywickrema; John C Reid; H Marie Loughran; Maria Kornienko; Sujata Sharma; Jay A Grobler; Bei Xu; Vinod Sardana; Timothy J Allison; Peter D Williams; Paul L Darke; Daria J Hazuda; Sanjeev Munshi
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

9.  Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.

Authors:  D Kögel; M Aboud; R M Flügel
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

10.  The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.

Authors:  Michael E Abram; Stefan G Sarafianos; Michael A Parniak
Journal:  Retrovirology       Date:  2010-02-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.